| 英文别名 |
Valacyclovir hydrochloride;VALACICLOVIR HCL;VALACICLOVIR HYDROCHLORIDE;VALACV;VALACYCLOVIR;L-VALINE 2-[(2-AMINO-1,6-DIHYDRO-6-OXO-9H-PURIN-9YL)METHOXY]ETHYL ESTER, HYDROCHLORIDE SALT;Valacyclovir Hydrochloride Hydrate;L-Valacyclovir Hydro;L-Valacyclovir Hydrochloride;VALACYCLOVIR HCL;2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester monohydrochloride;L-Valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-ylmethoxy)ethyl Ester Hydrochloride Hydrate;Valaciclovir;L-Valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-ylmethoxy)ethyl Ester Hydrochloride;9-((2-Hydroxy-ethoxy)methyl)guanine L-valine ester hydrochloride;HMS1922F20;VALACICLOVIR HYDROCHLORIDE [JAN];AC-8065;HY-17425A;Valacyclovir hydrochloride (USP);AKOS008901386;Z1546624231;Valaciclovir Hydrochloride,(S);NSC759101;Valacyclovir hydrochloride, United States Pharmacopeia (USP) Reference Standard;NC00139;BW 256;Valacyclovir hydrochloride (USAN:USP);(S)-2-((2-AMINO-6-OXO-1H-PURIN-9(6H)-YL)METHOXY)ETHYL 2-AMINO-3-METHYLBUTANOATE HYDROCHLORIDE;124832-27-5;BV164502;Q27888031;Valacyclovir HCl, Pharmaceutical Secondary Standard; Certified Reference Material;BW-256;Pharmakon1600-01505368;2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate;hydrochloride;Valaciclovir hydrochloride (JP17);SW197519-2;AKOS015951215;MFCD01861507;Valaciclovir (as hydrochloride);L-Valine, ester with 9-((2-hydroxyethoxy)methyl)guanine, monohydrochloride;VALACYCLOVIR HYDROCHLORIDE (USP-RS);DTXCID0024210;SCHEMBL40830;L-Valacyclovir hydrochloride- Bio-X;BW-256U87;VALACYCLOVIR HYDROCHLORIDE [USP MONOGRAPH];Valtrex;NSC-759101;KS-1126;2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate;hydrochloride;MLS001401440;VALACYCLOVIRHYDROCHLORIDE;256-U-87 HYDROCHLORIDE;Valacyclovir hydrochloride [USAN:USP];256U87 hydrochloride;SPECTRUM1505368;VALACICLOVIR HYDROCHLORIDE (EP MONOGRAPH);NCGC00159520-02;VALACICLOVIR HYDROCHLORIDE [MART.];VALACYCLOVIR HYDROCHLORIDE (USP MONOGRAPH);SureCN5665934;Valaciclovir hydrochloride (anhydrous), European Pharmacopoeia (EP) Reference Standard;CHEMBL1201110;NSC 759101;s1876;Tox21_111738_1;D00398;EN300-123056;G447S0T1VC;Valacyclovir HCl;Valaciclovir hydrochloride;VALACYCLOVIR HYDROCHLORIDE [ORANGE BOOK];BCP06722;SureCN1888797;VALACICLOVIR HYDROCHLORIDE ANHYDROUS;Valacyclovir hydrochloride [USAN];Valacyclovir (hydrochloride);2-((2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl L-valinate hydrochloride;NCGC00178638-02;SMR000469208;L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester, monohydrochloride;256u;VALACICLOVIR HYDROCHLORIDE (MART.);VALACYCLOVIR HYDROCHLORIDE [USP-RS];CCG-100889;VALACYCLOVIR HYDROCHLORIDE [VANDF];Valaciclovir for system suitability, European Pharmacopoeia (EP) Reference Standard;DTXSID2044210;L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine Hydrochloride;V0111;136489-37-7;VALACICLOVIR H... |